Skip to content

Chronic dietary modification versus supplementation with glycine betaine, on fasting and post-methionine load homocysteine concentrations in healthy volunteers.

A study to compare dietary modification versus supplementation with glycine betaine, on fasting and post-methionine load homocysteine concentrations in healthy volunteers.

Status
Not yet recruiting
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12606000104550
Enrollment
8
Registered
2006-03-20
Start date
2006-05-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

People with high blood levels of homocysteine are more likely to have heart attacks. Betaine helps keep homocysteine levels down. Many foods (including wheat-based breakfast cereals and some vegetables) are rich in betaine. In addition, betaine (also called “trimethylglycine”) can be purchased as a dietary supplement from health food stores. This research will investigate which approach has the greatest influence on homocysteine levels over a prolonged time period, eating more betaine in the diet or taking betaine in the form of dietary supplements. We hope to learn more about how betaine can be most effectively used to lower homocysteine and decrease the risk of heart attacks.

Interventions

Subjects will receive 2 treatments (a or b) in random order. Treatment a is a diet rich in glycine betaine (approximately 1500mg per day). The treatment duration will be two weeks, followed by a one week wash out period, and then a further two weeks on the alternative treatment.

Sponsors

Canterbury Health Laboratories
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Healthy volunteers with no previous history of vascular disease and no illness requiring medication, normal homocysteine concentration.

Exclusion criteria

The presence of vitamin B12, vitamin B6 or folate deficiency, and/or 677->T polymorphisms in the methylene reductase gene.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026